HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Robertson, J. S. Articles by Wood, J. M. Search for Related Content PubMed PubMed Citation Articles by Robertson, J. S. Articles by Wood, J. M. Agricola Articles by Robertson, J. S. Articles by Wood, J. M.

Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus

¹ National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG
and² Medical Centre, 46-62 Bank Street, Alexandria, Dumbartonshire G83 0LS, U.K.

We used the polymerase chain reaction to amplify the HA1 coding region of influenza A (H1N1) viruses present in clinical material from recent cases of influenza in the U.K. Previously, we have demonstrated that isolation of human influenza viruses in embryonated hens' eggs selects variants which have amino acid substitutions in their haemagglutinin (HA) clustering around the receptor-binding site. Such egg-selected variants are often antigenically distinct from each other and from corresponding viruses isolated on mammalian cells. Since in general the virus used for vaccine production is an egg-adapted virus, it is important to determine the extent to which these variants are present in the natural virus which causes disease in man. To achieve this, amplified products from clinical material were cloned and many individual clones sequenced. Our results indicate that the HA of the naturally occurring virus is relatively homogeneous and represented by virus isolated in the laboratory on MDCK cells, whereas the variants isolated in eggs are present only at low levels in clinical material.

Received 10 June 1991; accepted 2 August 1991.

This article has been cited by other articles:

				S. Watanabe, T. Watanabe, and Y. Kawaoka Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine J. Virol., June 1, 2009; 83(11): 5947 - 5950. [Abstract] [Full Text] [PDF]

				D. Y. Oh, I. G. Barr, J. A. Mosse, and K. L. Laurie MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells J. Clin. Microbiol., July 1, 2008; 46(7): 2189 - 2194. [Abstract] [Full Text] [PDF]

				B. Lu, H. Zhou, D. Ye, G. Kemble, and H. Jin Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse Genetics J. Virol., June 1, 2005; 79(11): 6763 - 6771. [Abstract] [Full Text] [PDF]

				I. V. Alymova, S. Kodihalli, E. A. Govorkova, B. Fanget, C. Gerdil, and R. G. Webster Immunogenicity and Protective Efficacy in Mice of Influenza B Virus Vaccines Grown in Mammalian Cells or Embryonated Chicken Eggs J. Virol., May 1, 1998; 72(5): 4472 - 4477. [Abstract] [Full Text] [PDF]